News and Events Recent News Jun 3, 2021 Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-APOC3 for Treatment of Severe Hypertriglyceridemia Jun 2, 2021 Arrowhead Pharmaceuticals to Participate in Upcoming Conferences May 18, 2021 Arrowhead Earns $10 Million Option Exercise Fee View More » Recent Events Jun 25, 2021 28th Annual FSHD Society International Research Congress Jun 23, 2021 - Jun 26, 2021 The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL) Jun 22, 2021 LifeSci Partners Genetic Medicines Summit 2021 View More »
Jun 3, 2021 Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-APOC3 for Treatment of Severe Hypertriglyceridemia
Jun 23, 2021 - Jun 26, 2021 The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL)